Company profile
Mynvax company profile
Mynvax is an Indian-based biotech startup that develops next-generation vaccines for influenza. In addition, the technology allows for very rapid, large-scale, and low-cost production of vaccines that could potentially be used to protect people when there is a pandemic. Mynvax, which was incubated at the Indian Institute of Science, was founded in 2017 by Raghavan Varadarajan and Gautham Nadig.
Business identity
- Website
- http://mynvax.com/
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 11-50 employees
- Revenue range
- $10M-$100M
- Founded
- 2017-05-05
Headquarters
- Headquarters
- Bengaluru, Karnataka, India
- Postal code
- 560041
- Country code
- IN
- Continent
- Asia